NCT02096835

Brief Summary

The purpose of this study is to access the effect of TEAS of P6 in the prevention of PONV in women scheduled for gynecologic laparoscopic surgery with general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 26, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
3 months until next milestone

Results Posted

Study results publicly available

April 10, 2015

Completed
Last Updated

October 12, 2015

Status Verified

October 1, 2015

Enrollment Period

11 months

First QC Date

March 24, 2014

Results QC Date

January 5, 2015

Last Update Submit

October 9, 2015

Conditions

Keywords

Postoperative nausea and vomitingTranscutaneous electrical acupoint stimulationGynecological laparoscopic surgeryTropisetronDexamethasone

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Experiencing Postoperative Nausea and Vomiting in 24h Postoperatively

    the total number including nausea, retching and vomiting within 24h after operation

    within 24h after operation

Secondary Outcomes (2)

  • Number of Participants Experiencing Postoperative Nausea in 24h Postoperatively

    within 24h after the operation

  • Number of Participants Experiencing Postoperative Vomiting in 24h Postoperatively

    within 24h after operation

Other Outcomes (1)

  • Need of Postoperative Metoclopramide

    within 48h after operation

Study Arms (3)

Acustimulation

EXPERIMENTAL

Transcutaneous electrical acupoint stimulation (TEAS) starts 30 min before surgery and lasts until patient leaves the postanesthetic care unit.Dexamethasone 10mg i.v. after induction.

Device: Transcutaneous electrical acupoint stimulationDrug: Dexamethasone

Tropisetron

ACTIVE COMPARATOR

Tropisetron 5mg iv. at the start of skin closure.Sham transcutaneous electrical acupoint stimulation.Dexamethasone 10mg i.v.after induction.

Device: Sham transcutaneous electrical acupoint stimulationDrug: TropisetronDrug: Dexamethasone

Control

SHAM COMPARATOR

Sham transcutaneous electrical acupoint stimulation. Dexamethasone 10mg i.v.after induction.

Device: Sham transcutaneous electrical acupoint stimulationDrug: Dexamethasone

Interventions

A surface electrode will be applied to the P6 acupoint on the dominant upper extremity, located approximately 3cm proximal to the distal wrist crease between the tendons of the flexor carpi radialis and the palmaris longus, and a negative surface electrode placed on the opposing dorsum aspect of the forearm.

Also known as: TEAS, Electrical neuromuscular stimulation device,JNR-2
Acustimulation

The same TEAS protocol will be applied unless silicone covers will be attached to both electrodes. The device will also be turned on during the procedure.

ControlTropisetron

will be given at the start of skin closure

Also known as: Tropisetron Hydrocloride Injection, Batch number:131001
Tropisetron

will be given after induction

AcustimulationControlTropisetron

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I or II
  • aged between 18 to 60yr
  • scheduled for elective gynecological laparoscopic surgery requiring general anesthesia

You may not qualify if:

  • pregnancy or breastfeeding
  • mental retardation
  • psychiatric or neurological disease
  • use of antiemetics, emetogenic drugs, opioids or glucocorticosteroids within 3 days prior to surgery
  • known allergy to tropisetron or dexamethasone
  • nausea and/or vomiting within 24 hr prior to surgery
  • implantation of a cardiac pacemaker, cardioverter, or defibrillator
  • any skin problem at the acupoint stimulation area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology, North Institute of Huashan Hospital,Fudan University

Shanghai, Shanghai Municipality, 201907, China

Location

Related Publications (1)

  • Yang XY, Xiao J, Chen YH, Wang ZT, Wang HL, He DH, Zhang J. Dexamethasone alone vs in combination with transcutaneous electrical acupoint stimulation or tropisetron for prevention of postoperative nausea and vomiting in gynaecological patients undergoing laparoscopic surgery. Br J Anaesth. 2015 Dec;115(6):883-9. doi: 10.1093/bja/aev352. Epub 2015 Oct 27.

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

TropisetronDexamethasone

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

IndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Results Point of Contact

Title
Dr.Xiaoyu Yang
Organization
Huashan Hospital Fudan University Shanghai, China

Study Officials

  • Jun Zhang, MD, PhD

    Department of Anesthesiology, North Institute of Huashan Hospital,Fudan University

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD.

Study Record Dates

First Submitted

March 24, 2014

First Posted

March 26, 2014

Study Start

January 1, 2014

Primary Completion

December 1, 2014

Study Completion

January 1, 2015

Last Updated

October 12, 2015

Results First Posted

April 10, 2015

Record last verified: 2015-10

Locations